- Filed
- May 10, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 13.9M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 14.38M sh |
| Capex | Q1 2024 · Mar 31, 2024 | $1.75M |
| Capex | Q1 2024 · Mar 31, 2023 | $5.41M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$28.86M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$13.66M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $108.21M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $90.28M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2023 | $95.02M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $299.3M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $311.54M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $297.35M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $302.69M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $657.89M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $674.24M |
| Total Assets | Q1 2024 · Mar 31, 2023 | $684.93M |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | −$0.94 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | $0.55 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | −$0.94 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | $0.55 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $35.41M |
| Sga Expense restated | Q1 2024 · Mar 31, 2023 | $33.78M |
| Net Income | Q1 2024 · Mar 31, 2024 | −$13.04M |
| Net Income | Q1 2024 · Mar 31, 2023 | $7.9M |
| Operating Income | Q1 2024 · Mar 31, 2024 | −$16.82M |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | −$11.09M |
| Revenue | Q1 2024 · Mar 31, 2024 | $78.48M |
| Revenue | Q1 2024 · Mar 31, 2023 | $92.13M |